CS247190B2 - Method of agent with porous matrix production on polycaprolactam base - Google Patents
Method of agent with porous matrix production on polycaprolactam base Download PDFInfo
- Publication number
- CS247190B2 CS247190B2 CS8510A CS1085A CS247190B2 CS 247190 B2 CS247190 B2 CS 247190B2 CS 8510 A CS8510 A CS 8510A CS 1085 A CS1085 A CS 1085A CS 247190 B2 CS247190 B2 CS 247190B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- weight
- polycaprolactone
- tablets
- une
- total
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 14
- 239000011159 matrix material Substances 0.000 title claims description 11
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 229920002292 Nylon 6 Polymers 0.000 title 1
- 229920001610 polycaprolactone Polymers 0.000 claims abstract description 23
- 239000004632 polycaprolactone Substances 0.000 claims abstract description 23
- 239000000203 mixture Substances 0.000 claims description 28
- 238000010438 heat treatment Methods 0.000 claims description 15
- 239000002245 particle Substances 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 7
- 239000000314 lubricant Substances 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 5
- 239000004014 plasticizer Substances 0.000 claims description 5
- 239000013078 crystal Substances 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 description 33
- 239000013543 active substance Substances 0.000 description 18
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 16
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- 239000001103 potassium chloride Substances 0.000 description 8
- 235000011164 potassium chloride Nutrition 0.000 description 8
- 239000008187 granular material Substances 0.000 description 7
- 239000000546 pharmaceutical excipient Substances 0.000 description 7
- 235000019359 magnesium stearate Nutrition 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000007906 compression Methods 0.000 description 4
- 230000006835 compression Effects 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 235000012239 silicon dioxide Nutrition 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000008119 colloidal silica Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000007908 dry granulation Methods 0.000 description 3
- 229920000915 polyvinyl chloride Polymers 0.000 description 3
- 239000004800 polyvinyl chloride Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 229920006243 acrylic copolymer Polymers 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000010438 granite Substances 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 229960001722 verapamil Drugs 0.000 description 2
- 241000167880 Hirundinidae Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- -1 for example Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229940114930 potassium stearate Drugs 0.000 description 1
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dental Preparations (AREA)
- Materials For Medical Uses (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8400015A FR2557459B1 (fr) | 1984-01-02 | 1984-01-02 | Matrice inerte a base de polycaprolactone pour administration orale d'un medicament, et procede de preparation de la forme galenique comprenant cette matrice |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS247190B2 true CS247190B2 (en) | 1986-12-18 |
Family
ID=9299789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS8510A CS247190B2 (en) | 1984-01-02 | 1985-01-02 | Method of agent with porous matrix production on polycaprolactam base |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4629624A (no) |
| EP (1) | EP0147335B1 (no) |
| JP (1) | JPS60185729A (no) |
| KR (1) | KR850005271A (no) |
| AT (1) | ATE33553T1 (no) |
| AU (1) | AU574024B2 (no) |
| CA (1) | CA1238856A (no) |
| CS (1) | CS247190B2 (no) |
| DD (1) | DD235829A5 (no) |
| DE (1) | DE3470459D1 (no) |
| DK (1) | DK616084A (no) |
| ES (1) | ES8605682A1 (no) |
| FI (1) | FI79942C (no) |
| FR (1) | FR2557459B1 (no) |
| GR (1) | GR82607B (no) |
| HU (1) | HU193731B (no) |
| IL (1) | IL73957A (no) |
| NO (1) | NO160412C (no) |
| OA (1) | OA08018A (no) |
| PH (1) | PH22167A (no) |
| PT (1) | PT79786B (no) |
| YU (1) | YU223884A (no) |
| ZA (1) | ZA857B (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU86077A1 (fr) * | 1985-09-18 | 1987-04-02 | Pharlyse Sa | Nouvelles formes galeniques du verapamil,leur fabrication et medicaments contenant ces nouvelles formes galeniques |
| DE3701625A1 (de) * | 1987-01-21 | 1988-08-04 | Boehringer Ingelheim Kg | Perorale arzneimittelzubereitung mit verzoegerter wirkstofffreigabe |
| SE8701479L (sv) * | 1987-04-09 | 1988-10-10 | Carbomatrix Ab | Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav |
| FR2627696B1 (fr) * | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
| GB8805286D0 (en) * | 1988-03-05 | 1988-04-07 | Schering Agrochemicals Ltd | Trypanocides |
| FR2758459B1 (fr) * | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
| FR2791569B1 (fr) * | 1999-03-31 | 2003-05-09 | Pf Medicament | Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention |
| US6531158B1 (en) | 2000-08-09 | 2003-03-11 | Impax Laboratories, Inc. | Drug delivery system for enhanced bioavailability of hydrophobic active ingredients |
| JP5069001B2 (ja) * | 2003-10-10 | 2012-11-07 | ベロクシス ファーマシューティカルズ エー／エス | フィブラートを含む固体投与形態 |
| US9173847B2 (en) * | 2003-10-10 | 2015-11-03 | Veloxis Pharmaceuticals A/S | Tablet comprising a fibrate |
| WO2005034908A2 (en) * | 2003-10-10 | 2005-04-21 | Lifecycle Pharma A/S | A solid dosage form comprising a fibrate and a statin |
| SA07280459B1 (ar) | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
| FR2912751B1 (fr) * | 2007-02-16 | 2012-07-13 | Arkema France | Procede de preparation de polylactones et polylactames |
| FR2912752B1 (fr) * | 2007-02-16 | 2012-10-05 | Arkema France | Procede de preparation d'un copolymere d'au moins un monomere cyclique |
| AU2013203747B2 (en) * | 2008-09-18 | 2016-01-07 | Purdue Pharma L.P. | Pharmaceutical dosage forms comprising poly(e-caprolactone) |
| NZ601200A (en) * | 2008-09-18 | 2014-02-28 | Purdue Pharma Lp | Pharmaceutical dosage forms comprising poly(epsilon-caprolactone) |
| CN104010630A (zh) * | 2011-12-09 | 2014-08-27 | 普渡制药公司 | 包含聚(ε-己内酯)和聚氧乙烯的药物剂型 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1490855A (fr) * | 1965-08-27 | 1967-08-04 | Shell Int Research | Procédé pour la fabrication d'articles en polyesters provenant de la polymérisation des lactones |
| US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US3929937A (en) * | 1972-07-28 | 1975-12-30 | Union Carbide Corp | Biodegradable shaped articles from a material comprising a particulate addition polymer in a matrix of a thermoplastic oxyalkanoyl polymer |
| US4095791A (en) * | 1976-08-23 | 1978-06-20 | Fairchild Camera And Instrument Corp. | Cartridge programmable video game apparatus |
| FR2377431A1 (fr) * | 1977-01-12 | 1978-08-11 | Inst Sint Smol | Procede de preparation de materiaux polymeres a pores ouverts |
| FR2397840B1 (no) * | 1977-07-22 | 1981-03-20 | Cherqui Jean | |
| US4148871A (en) * | 1977-10-11 | 1979-04-10 | Pitt Colin G | Sustained subdermal delivery ofdrugs using poly(ε-caprolactone) and its copolymers |
-
1984
- 1984-01-02 FR FR8400015A patent/FR2557459B1/fr not_active Expired
- 1984-12-20 DK DK616084A patent/DK616084A/da not_active Application Discontinuation
- 1984-12-21 FI FI845088A patent/FI79942C/fi not_active IP Right Cessation
- 1984-12-26 US US06/686,214 patent/US4629624A/en not_active Expired - Fee Related
- 1984-12-27 IL IL73957A patent/IL73957A/xx unknown
- 1984-12-28 ES ES539187A patent/ES8605682A1/es not_active Expired
- 1984-12-28 DE DE8484402753T patent/DE3470459D1/de not_active Expired
- 1984-12-28 YU YU02238/84A patent/YU223884A/xx unknown
- 1984-12-28 GR GR82607A patent/GR82607B/el unknown
- 1984-12-28 EP EP84402753A patent/EP0147335B1/fr not_active Expired
- 1984-12-28 AU AU37209/84A patent/AU574024B2/en not_active Ceased
- 1984-12-28 AT AT84402753T patent/ATE33553T1/de not_active IP Right Cessation
- 1984-12-28 NO NO845273A patent/NO160412C/no unknown
- 1984-12-29 JP JP59281898A patent/JPS60185729A/ja active Pending
- 1984-12-29 KR KR1019840008516A patent/KR850005271A/ko not_active Withdrawn
-
1985
- 1985-01-02 PT PT79786A patent/PT79786B/pt unknown
- 1985-01-02 ZA ZA857A patent/ZA857B/xx unknown
- 1985-01-02 PH PH31678A patent/PH22167A/en unknown
- 1985-01-02 DD DD85272341A patent/DD235829A5/de not_active IP Right Cessation
- 1985-01-02 CA CA000471365A patent/CA1238856A/en not_active Expired
- 1985-01-02 CS CS8510A patent/CS247190B2/cs unknown
- 1985-01-02 OA OA58495A patent/OA08018A/xx unknown
- 1985-01-02 HU HU858A patent/HU193731B/hu not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO160412B (no) | 1989-01-09 |
| DE3470459D1 (en) | 1988-05-26 |
| EP0147335B1 (fr) | 1988-04-20 |
| ZA857B (en) | 1985-08-28 |
| DK616084A (da) | 1985-07-03 |
| FI845088A0 (fi) | 1984-12-21 |
| PH22167A (en) | 1988-06-28 |
| ES8605682A1 (es) | 1986-04-01 |
| DD235829A5 (de) | 1986-05-21 |
| FI79942B (fi) | 1989-12-29 |
| HUT37567A (en) | 1986-01-23 |
| US4629624A (en) | 1986-12-16 |
| PT79786B (fr) | 1986-10-28 |
| AU3720984A (en) | 1985-07-11 |
| CA1238856A (en) | 1988-07-05 |
| YU223884A (en) | 1987-10-31 |
| EP0147335A2 (fr) | 1985-07-03 |
| JPS60185729A (ja) | 1985-09-21 |
| OA08018A (fr) | 1987-01-31 |
| IL73957A0 (en) | 1985-03-31 |
| FI845088L (fi) | 1985-07-03 |
| FR2557459A1 (fr) | 1985-07-05 |
| PT79786A (fr) | 1985-02-01 |
| FR2557459B1 (fr) | 1986-05-30 |
| NO845273L (no) | 1985-07-03 |
| EP0147335A3 (en) | 1985-07-31 |
| ES539187A0 (es) | 1986-04-01 |
| FI79942C (fi) | 1990-04-10 |
| KR850005271A (ko) | 1985-08-24 |
| NO160412C (no) | 1989-04-19 |
| ATE33553T1 (de) | 1988-05-15 |
| DK616084D0 (da) | 1984-12-20 |
| AU574024B2 (en) | 1988-06-23 |
| HU193731B (en) | 1987-11-30 |
| GR82607B (en) | 1985-02-11 |
| IL73957A (en) | 1988-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS247190B2 (en) | Method of agent with porous matrix production on polycaprolactam base | |
| FI82187B (fi) | Foerfarande foer framstaellning av lagerstabila snabbsoenderfallande farmaceutiska aktivaemnespresstycken. | |
| US5211958A (en) | Pharmaceutical composition and process for its preparation | |
| EP0250038B1 (en) | Sustained release capsule | |
| CA1228546A (en) | Oral mopidamol preparations | |
| AU756422B2 (en) | Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants | |
| US5057317A (en) | Slow-release pharmaceutical agent | |
| CA2182004C (en) | Film coated tablet of paracetamol and domperidone | |
| EP0218148A1 (en) | Slow-release pharmaceutical composition | |
| JPS61501151A (ja) | 拡散被覆された複合単位服用剤 | |
| EP1140034B1 (en) | Controlled release formulation of divalproex sodium | |
| US6419953B1 (en) | Controlled release formulation of divalproex sodium | |
| NZ201008A (en) | Oral preparations containing dipyridamole and at least 5 molar equivalents of orally acceptable acidic excipient | |
| KR20100020480A (ko) | Ｄｐｐ-ｉｖ 저해제를 위한 안정한 약제학적 제제 | |
| JP2001523719A (ja) | チアガビンを含有するスフェロイド、製造方法および医薬組成物 | |
| JPH03500288A (ja) | 徐放性ニフェジピン製剤 | |
| EP0500851A1 (en) | PROCESS FOR THE PREPARATION OF A COMPOSITION IN THE FORM OF A TABLET OR DRAGEE COMPRISING AN ACTIVE THERMOSENSITIVE, PHOTOSENSITIVE AND MOISTURE SENSITIVE INGREDIENT HAVING A MONOCLINIC CRYSTAL STRUCTURE. | |
| KR100315618B1 (ko) | 베타-페닐프로피오페논유도체의지연방출성미세정제 | |
| SI8710406A (en) | Sustained release tablets on the basis of high molecular weight hydroxypropylmethylcellulose and a process for their manufacture | |
| US4863741A (en) | Tablet composition for drug combinations | |
| KR20100041780A (ko) | 옥스카르바제핀을 포함하는 방출 제어형 고체 제제의 제조 방법 및 그에 의해 얻어질 수 있는 제제 | |
| EP0196002B1 (en) | Tablet composition for drug combinations | |
| JP2638604B2 (ja) | 徐放性製剤 | |
| JPH0130A (ja) | 徐放性製剤 | |
| EP4456983A1 (en) | Pharmaceutical compositions comprising macitentan as active ingredient and other relevant excipients |